Abstract Body

Background

Antiretroviral therapy (ART) has transformed HIV into a chronic condition with near-normal life expectancy, yet a gap remains due to inflammation-mediated comorbidities and serious non-AIDS events (SNAEs) such as cancer and cardiovascular disease that persist despite treatment. SNAE risk and mortality are particularly elevated in people with HIV (PWH) with unfavorable T-cell immunologic profiles (e.g., low CD4⁺ counts or a low CD4⁺/CD8⁺ ratio). Though specific mechanisms driving SNAE risk are poorly understood.

Methods

We performed a multi-omic analysis of 82 PWH at either high risk (n = 24) or low risk (n = 58) of SNAEs based on their T cell criteria. People at high risk were defined by having a CD4+ T cell count <350 or a CD4+/CD8+ ratio <0.4 after 2 years of ART. The plasma metabolome (255 metabolites) and lipidome (751 lipids) were measured by targeted LC-MS/MS. Plasma proteins (14 cytokines and 3 markers of gut barrier dysfunction) were measured by Luminex and ELISA and the microbiome of ileum and rectum gut biopsies were characterized by 16S sequencing. Multiple linear regression was used to compare biomarker concentrations between groups and correlation analysis was done using Spearman correlations. 

Results

High-risk participants showed higher plasma levels of the polyamine metabolite N¹,N⁸-diacetylspermidine and the dicarboxylic acids adipic and suberic acid. Ileal and rectal microbiomes were characterized by reduced commensal bacteria (e.g., Akkermansia muciniphila, Ruminococcus, Bacteroides uniformis) and increased Clostridia species including Intestinibacter bartlettii. The pro-inflammatory cytokine IL-6 was also elevated in the high-risk group. A. muciniphila abundance correlated inversely with plasma IL-6, IL-1β, and I-FABP concentrations, linking reduced mucosal commensals to systemic inflammation and gut barrier damage.

Conclusions

Elevated adipic and suberic acids suggest impaired fatty-acid oxidation with medium-chain dicarboxylic acid accumulation, consistent with mitochondrial stress and possible complex I dysfunction. Further, N¹,N⁸-diacetylspermidine is a reported colorectal cancer biomarker. Together with increased IL-6 and depletion of mucosal commensals such as A. muciniphila, these findings indicate a signature of mitochondrial dysfunction, inflammation, and dysbiosis in PWH at high risk for SNAEs. These data support testable mechanisms for SNAE pathogenesis and suggest metabolic and microbiome targets for adjunct therapies to mitigate SNAE development.